JAGLX

Janus Henderson Global Life Sciences Fund Class T [JAGLX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

JAGLX Stock Summary

Top 10 Correlated ETFs

JAGLX

Top 10 Correlated Stocks

JAGLX

In the News

JAGLX Financial details

Company Rating
-
Market Cap
5.37B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.05
Dividend %
0.07%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
8.45%
SMA50
13.24%
SMA100
18.46%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
61.61-75.13
52W High
+2.75%
52W Low
+26.33%
RSI
74
Rel Volume
-
Avg Volume
-
Volume
Perf Week
1.7%
Perf Month
11.6%
Perf Quarter
18.99%
Perf Half Y
14.45%
-
-
-
-
Beta
0.73
-
-
Volatility
0.7%, 2.67%
Prev Close
0%
Price
77.06
Change
0%

JAGLX Financial Performance

JAGLX Dividend History

JAGLX Frequently Asked Questions

What is Janus Henderson Global Life Sciences Fund Class T stock symbol ?

Janus Henderson Global Life Sciences Fund Class T is a US stock and trading under the symbol JAGLX

What is Janus Henderson Global Life Sciences Fund Class T stock quote today ?

Janus Henderson Global Life Sciences Fund Class T stock price is $77.06 today.

Is Janus Henderson Global Life Sciences Fund Class T stock public?

Yes, Janus Henderson Global Life Sciences Fund Class T is a publicly traded company.

Something similar

Top by Market Cap
CMC.DE
FXAIX
BRK-A
M&M.NS
3V64.DE
Top Correlated ETFs
IBB
BIB
IBBQ
HSEU.L
XBI
Top Correlated Stocks
FSPHX
SHSKX
SHSSX
SHSAX
RGEN
Similar Market Cap
601968.SS
AGCP.L
002455.SZ
SIX2.DE
4441.T

Company Profile

Financial Services Asset Management - Global
  • Market Capitalization 5.37B
  • Headquarters US
  • IPO Date 1998-12-31

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.